Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05143619
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Survey Administration — OTHERComplete surveys
Study Details
This study evaluates a concept called 'Teaching the Teachers' and whether it is helpful in disseminating guidelines on the national and international levels. "Teaching the Teachers" involves teaching the guidelines to experts who later teach the same guidelines to other radiologists, trainees, and physicians to assume the teacher's role and disseminate the guidelines and so on.
Key Dates
- Start date
- May 10, 2019
- Status verified
- Apr 2026
- Primary completion
- Feb 2, 2027
- Completion
- Feb 2, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Observational (surveys)Participants complete surveys immediately after completion of a HCC diagnostic guideline webinar, monthly thereafter, and again at 6 months.
Primary Outcome Measure
Teaching rates of the hepatocellular carcinoma diagnosis guidelines [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Khaled M Elsayes, MD(713) 794-1191
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Khaled M. Elsayes, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCPHASE1/PHASE2 · Recruiting · Eureka Therapeutics Inc. · Duarte, California
- Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma PatientsPHASE2 · Enrolling By Invitation · The Methodist Hospital Research Institute · Houston, Texas
- Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan CriteriaPHASE4 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Multi-analyte Blood Test Clinical TrialRecruiting · Helio Genomics · Mission Hills, California